作者:Carolyn C. Woodroofe、Poncho L. Meisenheimer、Dieter H. Klaubert、Yumi Kovic、Justin C. Rosenberg、Curran E. Behney、Tara L. Southworth、Bruce R. Branchini
DOI:10.1021/bi301411d
日期:2012.12.11
Five novel fireflyluciferinanalogues in which the benzothiazole ring system of the natural substrate was replaced with benzimidazole, benzofuran, benzothiophene, benzoxazole, and indole were synthesized. The fluorescence, bioluminescence, and kinetic properties of the compounds were evaluated with recombinant Photinus pyralis wild type luciferase. With the exception of indole, all of the substrates
The invention encompasses a series of benzothiazole compounds which inhibit HIV entry and are useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for using these compounds.
We report herein on a catalytic system involving palladium and copper to achieve the cyclization of N-arylcyanothioformamides and the synthesis of 2-cyanobenzothiazoles. The C-H functionalization/intramolecular C-Sbond formation reaction was achieved in the presence of air, using 2.0 equiv of an inorganic additive (KI). In many cases, the reaction led to a sole product regioselectively obtained in
Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound
申请人:FUJIFILM Corporation
公开号:US11319347B2
公开(公告)日:2022-05-03
An object of the present invention is to provide a novel cyclic peptide compound excellent in cell membrane permeability, a method for producing the same, a composition for screening use, and a method for selecting a cyclic peptide compound that binds to a target substance. According to the present invention, a peptide compound represented by Formula (1) or a salt thereof is provided. In the formula, the symbols have the meanings as defined in the specification of the present application.